Updates are available Correction dated 2023-06-28
Click to view Correction: https://doi.org/10.1007/s40262-023-01276-w
-
Authors
van Hout, Marloes http://orcid.org/0000-0002-5753-9563
Forte, Pablo http://orcid.org/0000-0001-9355-7067
Jensen, Thomas B. http://orcid.org/0000-0002-8920-9374
Boschini, Cristina http://orcid.org/0000-0001-6905-7038
Bækdal, Tine A. http://orcid.org/0000-0002-1348-0352
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04513704 at ClinicalTrials.govDocuments that mention this clinical trial
Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects
https://doi.org/10.1007/s40262-023-01223-9
-
Funding
Funding for this research was provided by:
Novo Nordisk A/S
- License Information
-
More Information
Article History
Accepted: 8 February 2023
First Online: 17 March 2023
Change Date: 28 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40262-023-01276-w
Declarations
:
: This trial and medical writing support for the publication were funded by Novo Nordisk A/S, Søborg, Denmark.
: MvH, TBJ, CB, and TAB are employees, and MvH, TBJ, and TAB are shareholders, of Novo Nordisk A/S, the sponsors of this trial. PF is an employee of PAREXEL International.
: Data are available upon reasonable request. Data will be shared with bona fide researchers submitting a research proposal approved by the independent review board. Access request proposals can be found at novonordisk-trials.com. Data will be made available after research completion, and approval of the product and product use in the European Union and the USA. Individual participant data will be shared in data sets in a de-identified/anonymised format.
: The trial was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. The protocol was approved by an independent ethics committee (South Central—Berkshire B Research Ethics Committee).
: Not applicable.
: Not applicable.
: All participants provided written informed consent.
: MvH, TAB, CB, and TBJ designed the trial; PF, MvH, TAB, and TBJ conducted the trial/performed data collection; CB, TAB, TBJ, and MvH analysed the data; all authors drafted and revised the manuscript and approved the final version.
